ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Clinical Practice Session

Glomerulonephritis in Systemic Diseases: Emphasis on Emerging Therapies and Prognosis

November 04, 2022 | 02:00 PM - 04:00 PM

Location: W415 Valencia, Orange County Convention Center‚ West Building

Session Description

For decades, systemic diseases characterized by glomerular and other vascular involvement have been treated primarily with corticosteroids and other highly nonspecific immunosuppressive agents. However, an increased understanding of the pathogenesis of these diseases has led to newer treatment approaches, some currently in use and others in development and in clinical trials. This session focuses on such approaches in several systemic diseases that frequently manifest as glomerulonephritis (GN) and vasculitis.

Support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

  • Discuss new findings on clinical-pathologic correlations in and therapeutic approaches to nephritis in IgA vasculitis
  • Describe current and emerging therapeutic approaches to ANCA GN and vasculitis and to cryoglobulinemic GN and vasculitis based on pathogenic insights
  • Summarize new and emerging treatment options for patients with lupus nephritis

Learning Pathway(s)

  • Glomerular Diseases


  • Isabelle Ayoub, MD, MPH, FASN
  • Dana Rizk, MD